Rochester, NY, United States
Rochester, NY, United States

Time filter

Source Type

"A diagnosis of lung cancer shouldn't happen by chance or when the disease is in its later stages, as it does for so many," said Harold Wimmer, National President and CEO of the American Lung Association. "We know that early detection is key – survival rates are five times higher when lung cancer is detected early. This is why awareness of lung cancer and screening options is critical in partnership with research funding to support more treatment options and methods of early detection." The American Lung Association's 3rd annual Women's Lung Health Barometer revealed that, while there have been positive shifts in women's perceptions of lung cancer, awareness remains critically low. Anyone can get lung cancer, and sadly one woman dies every eight minutes in the U.S. from the disease. Early detection and treatment of lung cancer translates to higher survival rates, however only 18 percent of lung cancer cases among women are diagnosed early, when the disease is most treatable. Survivor: Millennials vs. Gen X 2016 victor Adam Klein has joined the LUNG FORCE initiative as a LUNG FORCE Hero after losing his mother to lung cancer just one hour after returning home from the competition. Klein's mother, Susie, lost her life to the disease only nine short months after receiving a stage 4 lung cancer diagnosis. In honor of his mother's legacy, Klein most recently participated in LUNG FORCE's 2nd Annual LUNG FORCE Advocacy Day in Washington, D.C., to advocate for additional research funding. "My mother was an inspirational woman, filled with strength, love and compassion. She bravely faced the disease for nine months, but more importantly, thrived for 60 years," said Klein. "Lung cancer is the number one cancer killer of women and yet only 2 percent of women have lung cancer on their health radar so it's imperative that we make it a priority. Early detection and more effective treatment options will save lives which is why I've committed myself to raising awareness of lung cancer as well as critical funding for research in the fight against this disease." LUNG FORCE Kicks Off Social Campaign #ShowYourLUNGFORCE Without our lungs, we could not sing, dance, run or laugh – we couldn't breathe. LUNG FORCE is celebrating the power of our lungs by demonstrating the many ways we use them every day. To encourage people to take a stand against lung cancer, LUNG FORCE is launching a social campaign called #ShowYourLUNGFORCE, asking Americans to take action and mobilize their social networks to amplify awareness and raise funds to defeat lung cancer. It's easy for everyone to get involved: Donations will support the American Lung Association's investment in lung cancer research and patient support – including early detection, biomarker testing and advocacy for more federal research funding. For the fourth year in a row, LUNG FORCE National Presenting Sponsor CVS Health is rallying support with in-store fundraising. From Sunday, May 7th through Saturday, May 27th, CVS Pharmacy customers can visit any of its 7,900 stores to support LUNG FORCE by making a $1, $3 or larger donation at the register or online at Lung.org/CVS to raise funds for lung cancer awareness, research and education. The in-store fundraising campaign is part of Be The First, a 5-year $50 million initiative funded through CVS Health and the CVS Health Foundation to help deliver the nation's first tobacco-free generation. While anyone can get lung cancer, smoking is the leading risk factor for lung cancer, along with radon gas, air pollution and secondhand smoke exposure. In addition to donating to the campaign, customers can also visit Lung.org/CVS for easy ways to help their communities become tobacco-free, which is key to making a difference against lung cancer. "CVS Health is a proud sponsor of LUNG FORCE and its work to ensure that we fight the number one cancer killer," said Helena Foulkes, President, CVS Pharmacy. "As a company that is committed to helping people on a path to better health, we want to help raise funds and spread awareness of this deadly disease. Together with the American Lung Association's LUNG FORCE, we're working to create tobacco-free communities to help beat lung cancer." For more information about LUNG FORCE including local LUNG FORCE Walks taking place throughout May, visit LUNGFORCE.org. About The American Lung Association The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. About LUNG FORCE LUNG FORCE is a national initiative led by the American Lung Association to unite women against lung cancer, the #1 cancer killer of women. LUNG FORCE has three priorities: 1) Make lung cancer a cause that people care about – and act on; 2) Educate and empower patients and healthcare providers and 3) Raise critical funds for lung cancer research. The American Lung Association's LUNG FORCE is nationally presented by CVS Health. Find out more at LUNGFORCE.org About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at CVSHealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-lung-associations-lung-force-encourages-americans-to-take-action-against-the-no-1-cancer-killer-during-national-womens-lung-health-week-may-7-13-300454084.html


News Article | May 11, 2017
Site: www.prnewswire.com

"While today's decision was extremely difficult, we believe this action is necessary to preserve the value of the business as we seek a sale," said Chief Executive Officer Tom O'Boyle. "After reviewing every alternative, we concluded that Chapter 11 clearly provides the most effective and efficient means to ensure the best recovery for the Company's stakeholders." The Company has retained Peter J. Solomon Company as investment bank to market its assets. The Chapter 11 filing permits daily operations to continue without interruption. The stores will remain open and serving customers, employees will continue to receive their usual salary and benefits, and goods and services purchased by the Company, after the May 11, 2017 filing date, will be paid for in the ordinary course of business. As is customary, the filing triggers an automatic stay, which precludes the Company from paying amounts owed for pre-petition goods and services without a Court order. The Company has asked the Bankruptcy Court's permission to use its available cash to fund operations during this period, since the Company's Secured Lenders have already agreed to allow the Company to do so. The Company expects to have sufficient liquidity to fund operations throughout the sale process. Besides use of its cash, the Company also has sought approval to pay its employees and provide benefits as normal, to continue customer programs as normal, and to continue the closing store sales at select locations. Marsh Supermarkets was founded in Muncie, Indiana, in 1931 by Ermal Marsh. Throughout its history, Marsh has been a leader in technology, becoming the nation's first grocery chain to ring up purchases with electronic scanners and the first to adopt a system that wirelessly delivers coupons to customers' smart phones as they shop. As a company that has long been a landmark in its region, Marsh is hoping to find the right buyer so that we can continue to serve families across Indiana and Ohio. In recent years, the Company has struggled to compete effectively against larger national and regional chains that have made the Indiana and Ohio grocery marketplace among the nation's most competitive. The crowded environment has led to price-cutting and other forms of promotional activity that have put profit margins under extreme pressure. Marsh has reacted this year by closing 21 unprofitable stores and, in late April, the sale of its in-store pharmacy business to Hook-SupeRx, L.L.C., a subsidiary of CVS Pharmacy. The result is a chain of 44 stores that Marsh believes can be a valuable acquisition or merger partner for a grocery company or other buyer. Marsh is represented by Robert S. Brady and Michael R. Nestor of the law firm Young Conaway Stargatt & Taylor, LLP. Lee Diercks, Partner of the Clear Thinking Group LLC, is acting as Chief Restructuring Officer and Clear Thinking Group LLC is acting as the Company's Financial Advisor. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/marsh-supermarkets-llc-initiates-marketing-process-for-remaining-stores-300456105.html


News Article | May 16, 2017
Site: www.prnewswire.com

The combined 25,000 square feet of retail space will be anchored by a flex format Target store featuring a Starbucks and CVS Pharmacy. Firecakes Donuts will occupy the space closest to the transit station and Wheel & Sprocket plans to open this summer in the adjacent 1118 Westgate building. First move-ins are anticipated for Aug. 1 with construction completing in October. "We're very excited to open our doors in downtown Oak Park," said Ryan McBride, vice president of development for LMC. "This community has been a long time coming and we're thrilled to begin building our resident base. Oak Park provides a one-of-a-kind living experience with its vibrant restaurant, retail and cultural scene. We look forward to being a part of it." Situated at 1135 Westgate Street, The Emerson is a 15-minute ride from Downtown Chicago via the adjacent Metra commuter line and 'L' Station. Interstate 290 is two miles from the community, providing access to the key attractions and employment centers in both the city and suburbs. The community is adjacent to Lake Street and Marion retail corridor and within walking distance of a Whole Foods Market, Trader Joe's, Walgreens, Lake Street Theater and several other local and national dining, entertainment and shopping destinations. The Emerson consists of studio, 1- and 2-bedroom apartments with a top-of-the-line community amenities package. Included are a heated outdoor swimming pool, private cabanas with resort-quality outdoor furniture, high-end outdoor grills, landscaped outdoor deck with city views, state-of-the-art fitness center, spacious multi-sport training studio and a business center with private offices. Residents also will have access to a digital-package and dry-cleaning locker system. Apartment interiors feature quartz countertops, stainless steel appliances, European-style custom cabinetry with under-cabinet lighting in select units, glass tile backsplashes, tile shower surrounds with frameless glass doors, in-unit washers and dryers and luxury vinyl-plank flooring. Including The Emerson, LMC has more than 1,000 apartment homes in operation, planned or under construction in the Chicago area. About LMC LMC, a wholly owned subsidiary of Lennar (NYSE: LEN), is a multifamily real estate development and operating company with a diverse portfolio of institutional quality multifamily rental communities across the US. LMC has a 23,000-unit pipeline of communities ranging from operating to under development that exceeds $7 billion and consists of high-rise, mid-rise and garden apartments. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lmc-announces-start-of-preleasing-at-the-emerson-apartments-300457832.html


"The opioid epidemic is an urgent public health crisis facing Arizona and the entire country," said Attorney General Mark Brnovich. "We want to ensure that Arizona families who have loved ones struggling with addiction have access to Naloxone because it saves lives." "As a lawmaker, it's always rewarding to see the policy decisions we make put into practice," said Representative Heather Carter. "The main purpose behind the legislation I sponsored was to get this medication in the hands of a person who may have an opportunity to save a life.  I'm here today to recognize a critical step toward achieving this goal." Today's naloxone announcement builds on CVS Health's longstanding commitment to helping communities address and prevent drug abuse.  In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 250,000 students across the U.S. have already taken part in the program, including nearly 8,000 students in Arizona.  High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com. CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication.  Police departments in Arizona can apply to receive a drug collection unit at www.cvs.com/safercommunities.  Additionally, CVS Health has launched digital resources on its website CVS.com that give patients and families a single destination to learn more about drug abuse prevention. With the addition of Arizona, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 41 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin. CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/attorney-general-brnovich-rep-carter-join-cvs-health-to-announce-availability-of-naloxone-at-all-cvs-pharmacy-locations-in-arizona-300462478.html


News Article | May 25, 2017
Site: www.businesswire.com

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The United States Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) recently issued decisions invalidating patent claims in three patents asserted against various retailers, including Walgreens, a longtime partner of Quotient Technology Inc. (NYSE:QUOT). “This is a huge victory for us and our partners,” said Steven Boal, CEO of Quotient. “Although the claims weren’t against Quotient’s technology, we helped fight baseless litigation targeting the industry. The plaintiff publicly said that roughly 40 retailers would be subject to these patents. Well, we thought differently, and with this ruling sent them and others a strong message.” The PTAB decisions stem from an aggressive campaign by Connecticut-based Advanced Marketing Systems against retailers with digital coupon programs, beginning with a lawsuit against The Kroger Co. in 2014, which reached a settlement later that year. In 2015, in addition to Walgreens, AMS sued Ahold USA, Inc., Delhaize America, Inc., Brookshire Grocery Company, CVS Pharmacy, Inc., Hy-Vee Inc., Ingles Markets Inc., and Publix Super Markets. AMS alleged that the retailers provided websites and mobile apps for loading digital coupons to rewards cards that infringed three AMS patents. Specifically, AMS alleged infringement of claim 9 of U.S. Patent No. 8,219,445, claim 1 of U.S. Patent No. 8,538,805, and claims 15 and 28 of U.S. Patent No. 8,370,199. Quotient (identified as a real party-in-interest), along with some of the retailers, including Walgreens, challenged the validity of the AMS patents, filing requests with the PTAB for what’s called covered business method patent reviews (CBMs). After the PTAB instituted review of the patents, the ongoing district court cases filed by AMS were put on hold pending the outcome of the CBMs. Just recently, the PTAB ruled in our favor, invalidating all challenged claims, which are the same claims AMS asserted in the district court cases. “When we reviewed the AMS patents and prior art, we knew we had to assist our partners in challenging the validity of the patents at the PTAB,” said Connie Chen, General Counsel of Quotient. “We’re delighted that the PTAB agreed with our arguments and found that the asserted patent claims were unpatentable.” The ramifications of the PTAB decisions are not only significant for Quotient and its partners, but all retailers with digital couponing programs. Quotient Technology Inc. (NYSE: QUOT) is a leading digital promotion, media and analytics company that connects brands, retailers and consumers. We distribute digital coupons and media through a variety of products, including digital paperless coupons, digital printable coupons, coupon codes and card-linked offers. We operate Quotient Retailer iQ™, a real-time digital coupon platform that connects into a retailer’s point-of-sale system and provides targeting and analytics for manufacturers and retailers. Our distribution network includes our flagship app and site, Coupons.com, as well as Grocery iQ™, our thousands of publisher partners and, in Europe, the Shopmium mobile app. We serve hundreds of consumer packaged goods companies, such as Clorox, Procter & Gamble, General Mills and Kellogg’s, as well as top retailers like Albertsons Companies, CVS, Dollar General, Kroger and Walgreens. Founded in 1998, Quotient is based in Mountain View, Calif. Learn more at Quotient.com, and follow us on Twitter @Quotient.


The following material contains graphic images that may be disturbing. Parents are advised that these images may not be suitable for young children. Matt and Patrice have to be very careful how they touch their beloved son, even though he touches their hearts every day. Jonah suffers from epidermolysis bullosa (EB), a rare skin disorder that causes his skin to blister or slide off at the slightest friction. The couple lost their first child late in pregnancy. Two months later they conceived again, but when their baby was born his skin was missing in places and he was screaming in agony. “It wasn’t the normal newborn baby cry that you want to hear – it was agony.” A pediatrician quickly diagnosed Jonah with epidermolysis bullosa, and told Patrice and Matt the bad news. There is no cure or treatment for the condition. “So is the only option prayer? Is that the only choice we’ve got?” Matt asked -- the doctor responded, “Yes.” Jonah needs assistance in the bathroom, and his dressings must be changed three to four times a week. “There is no part of his body that doesn’t blister,” Patrice explains. Jonah also suffers internal complications, so he now has a feeding tube. “Jonah has never known a life without pain.” However, Patrice says, “In spite of all the pain he goes through, he is just the funniest, most joyful, most charismatic little kid you’ll ever meet.” Matt adds, “It’s kind of weird for a dad to say that their son is their hero, but Jonah definitely is my hero.” Says Patrice, “He doesn’t just survive – he thrives.” Watch: Teen's Skin Is Causing Her Emotional and Physical Pain ER Physician Dr. Travis Stork wonders how Matt and Patrice cope with not being able to hug and cuddle their son freely. “We’ve just learned how to do it,” Patrice explains. “We certainly don’t deprive him of touch or affection.” It’s difficult with Jonah’s four-year-old brother, though, who wants to rough-house with his big brother. “I just intervene a lot!” says Patrice. Dermatologist Dr. Sonia Batra explains that there are several varieties of EB. In Jonah’s case, the upper layer of his skin, the epidermis, is not properly connected the layer below. So any touch can cause the two levels to shear and separate. Infection is a constant danger, and so is malnutrition because the body is constantly using resources to heal. Patrice and Matt sponsor running events to raise funds for debra of America, the national advocacy organization for EB. “Most local doctors don’t necessarily know what it is either, so you have to have somewhere to turn and that’s what they are,” Patrice explains. The Doctors have reached out to support their efforts. CVS Pharmacy and Molnycke Health Care have partnered to provide a year’s worth of bandages to debra of America! Molnycke will also provide a $1,000 CVS gift card to Matt and Patrice for Jonah’s medical supplies. But the best surprise is for Jonah himself! The little boy loves cars and racing, and has a list of favorite NASCAR drivers. Now drivers Dale Earnhardt Jr., Jimmie Johnson, Danica Patrick, Jeff Gordon, Kyle Busch, and Chase Elliott, Kevin Harvick, Joey Logano, Kurt Busch, and Kasey Kahne have made a video to thank him for being a fan, and to invite him and his family to join them at the races! “That’s totally awesome!” Jonah exclaims. And it's not just racing tickets – he’s going home with NASCAR t-shirts, caps, toys, and more. “Will all that fit in our suitcase?” he wonders. “This is amazing!”


— Pharmacy Retailing is drugs sold in the retail and bought on the internet, not in the hospital. This report focuses on the Pharmacy Retailing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. For more information or any query mail at sales@wiseguyreports.com Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Applications, can be divided into OTC Rx Complete Report Details @ https://www.wiseguyreports.com/reports/931952-global-pharmacy-retailing-market-forecast-to-2022 There are 15 Chapters to deeply display the global Pharmacy Retailing market. Chapter 2, to analyze the top manufacturers of Pharmacy Retailing, with sales, revenue, and price of Pharmacy Retailing, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Retailing, for each region, from 2012 to 2017; 2 Manufacturers Profiles 2.1 CVS 2.1.1 Business Overview 2.1.2 Pharmacy Retailing Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CVS Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Walgreen 2.2.1 Business Overview 2.2.2 Pharmacy Retailing Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Walgreen Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Rite Aid 2.3.1 Business Overview 2.3.2 Pharmacy Retailing Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Rite Aid Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Loblaw 2.4.1 Business Overview 2.4.2 Pharmacy Retailing Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Loblaw Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Diplomat 2.5.1 Business Overview 2.5.2 Pharmacy Retailing Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Diplomat Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Ahold? 2.6.1 Business Overview 2.6.2 Pharmacy Retailing Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Ahold? Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 AinPharmaciez 2.7.1 Business Overview 2.7.2 Pharmacy Retailing Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 AinPharmaciez Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Guoda Drugstore 2.8.1 Business Overview 2.8.2 Pharmacy Retailing Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Guoda Drugstore Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Yixintang 2.9.1 Business Overview 2.9.2 Pharmacy Retailing Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Yixintang Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Albertsons 2.10.1 Business Overview 2.10.2 Pharmacy Retailing Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Albertsons Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Pharmacy Retailing Market Competition, by Manufacturer 3.1 Global Pharmacy Retailing Sales and Market Share by Manufacturer 3.2 Global Pharmacy Retailing Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Pharmacy Retailing Manufacturer Market Share 3.3.2 Top 6 Pharmacy Retailing Manufacturer Market Share 3.4 Market Competition Trend 4 Global Pharmacy Retailing Market Analysis by Regions 4.1 Global Pharmacy Retailing Sales, Revenue and Market Share by Regions 4.1.1 Global Pharmacy Retailing Sales by Regions (2012-2017) 4.1.2 Global Pharmacy Retailing Revenue by Regions (2012-2017) 4.2 North America Pharmacy Retailing Sales and Growth (2012-2017) 4.3 Europe Pharmacy Retailing Sales and Growth (2012-2017) 4.4 Asia-Pacific Pharmacy Retailing Sales and Growth (2012-2017) 4.5 South America Pharmacy Retailing Sales and Growth (2012-2017) 4.6 Middle East and Africa Pharmacy Retailing Sales and Growth (2012-2017) 5 North America Pharmacy Retailing by Countries 5.1 North America Pharmacy Retailing Sales, Revenue and Market Share by Countries 5.1.1 North America Pharmacy Retailing Sales by Countries (2012-2017) 5.1.2 North America Pharmacy Retailing Revenue by Countries (2012-2017) 5.2 USA Pharmacy Retailing Sales and Growth (2012-2017) 5.3 Canada Pharmacy Retailing Sales and Growth (2012-2017) 5.4 Mexico Pharmacy Retailing Sales and Growth (2012-2017) For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | February 16, 2017
Site: www.businesswire.com

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global personalized gifts market to grow at a CAGR of more than 9% during the forecast period, according to their latest report. The research study by Technavio on the global personalized gifts market for 2017-2021 provides detailed industry analysis based on skill and technology (hand decoration, embroidery, engraving, printing, and carving), product (photo and non-photo personalized gifts), retail format (in-store and online), and geography (the Americas, Europe, APAC, and MEA). Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more. Technavio analysts highlight the following three key factors that are contributing to the growth of the global personalized gifts market: “The gifting culture is evolving with an increasing number of occasions when gifts are exchanged. Consumers customize gifts through personalization, configuration, or on-demand printing to add value and make their gifts unique,” says Poonam Saini, one of the lead analysts at Technavio for retail goods and services research. Seasonal decorations, such as decorative cups, plates, and napkins, account for a major portion of the total revenue generated in the market. Also, the growing home and wall décor market have also been aiding in the expansion of the growth opportunities for personalized gifts. The demand for these gifts usually experiences a surge during holidays like Christmas, Halloween, Easter, and Hanukkah. Product innovation is a requisite for this market to generate consumer interest and as an extension, its sales. A notable example is Hallmark's recent launch of Hollywood-inspired decorative ornaments based on the popular characters from popular movies, which created a lot of revenue for the market. Currently, eco-friendly gifts and novelty items are garnering significant consumer interest, particularly in children’s toys. Also, to retain consumer loyalty and increase sales, manufacturers are streamlining design and building more efficient ordering processes, enhancing customization capabilities, and brainstorming new ideas. “Retail participation across various distribution channels is an important factor that determines the growth of the global personalized gifts market. Even in the digital age, a high percentage of consumers prefer buying goods from brick-and-mortar stores, due to the personalized nature of these products,” says Poonam. Mass merchandisers, such as Walmart and Target, and pharmacy chains such as CVS Pharmacy and Rite Aid have equipped their stores with dry minilabs, which can provide on-site photo personalized gifts. Additionally, gaining consumer interest and building a brand image through the social media platform is increasing as it is cost-effective and it usually gets faster responses from a large customer base. Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cosmetics and toiletry, luggage, and pet supplies. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently. Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies. Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users. If you are interested in more information, please contact our media team at media@technavio.com.


News Article | January 12, 2017
Site: www.techtimes.com

CVS has announced that it would sell a generic version of an EpiPen competitor at a far lower price than that of the controversial EpiPen. The nation's largest drugstore chain announced on Thursday that it would sell the generic version of Impax Laboratories' Adrenaclick treatment for life-threatening allergic reactions. CVS' move is apparently a bid to offer consumers a more affordable but safe alternative to Epipen amid the skyrocketing cost of Mylan's controversial epinephrine autoinjector and following Trump lambasting drugmakers on Wednesday, Jan. 11, for the hikes in drug prices. Epipen delivers epinephrine, a synthetic adrenaline that can counter the potentially deadly effects of severe allergic reactions. People suffering from food allergies rely on Epipens for life-saving treatment, but the price of the autoinjector has swollen over the past years, making it too prohibitive for some families. In 2009, a two-pack Epipens costs only around $100, but the price has since skyrocketed to more than $600. In an effort to save, some Americans resorted to using do-it-your-own alternatives that, when used incorrectly, can have serious and even deadly consequences. Mylan, in an effort to appease the public's resentment over the pricey cost of its autoinjector, said that it would start selling a generic version of the EpiPen for $300 per two-pack, which is more than 50 percent cheaper than the price of the regular Epipen. Adrenaclick is a lesser-known epinephrine delivery product that was green-lighted by the Food and Drug Administration in 2003. Regulators do not consider it as an exact copy of the EpiPen, but it contains the same active ingredient found in Mylan's autoinjector. Adrenaclick administers the drug through a slightly different injection. CVS said that it would offer the authorized generic of Adrenaclick two-pack at $109.99 for insured and cash-paying patients without insurance, which means that it would be offered at about 80 percent of the current EpiPen price. The price of generic Adrenaclick remains cheaper even when compared with that of the generic version of EpiPen. Additional cost reductions for the generic Adrenaclick can also be availed by qualified patients who use the coupon programs offered through Impax that would provide a benefit of $100 per pack. "We are thrilled to work with CVS Health to increase access to our low-cost generic Adrenaclick epinephrine auto-injector," said Douglas Boothe, president of Generics Division at Impax Laboratories. "Families need and deserve an affordable option to treat severe allergies." CVS Pharmacy president Helena Foulkes said that Medicaid and Medicare plan members won't qualify for the $100 coupon, but CVS pharmacists will work with customers to determine the cheapest route to acquire the treatment. Foulkes said that the company responded after hearing streams of concern from customers complaining about the price increases of EpiPen. "Our focus has always been on finding solutions for patients first and foremost," Foulkes said. "The best thing that can happen to keep drug prices low is to have a lot of competition in the marketplace." © 2017 Tech Times, All rights reserved. Do not reproduce without permission.


WOONSOCKET, R.I., Feb. 22, 2017 /PRNewswire/ -- CVS Pharmacy is the first national retail pharmacy chain to announce the removal of partially hydrogenated oils (PHO), the primary source of artificial trans fats in processed foods, from all its exclusive store brands food products. The...

Loading CVS Pharmacy collaborators
Loading CVS Pharmacy collaborators